HHS Maps US Medical Plants to Spot Supply Chain Risks
The Administration for Strategic Preparedness and Response, an HHS agency, is working with manufacturers and government partners to map US medical production and find where the supply chain could break, according to Becker's Hospital Review.
The effort runs through ASPR's Center for Industrial Base Management and Supply Chain, which is examining dependencies across the medical production chain. The goal is to locate the points where additional domestic capability could reduce reliance on single suppliers or foreign sources, so essential products stay available when demand spikes.
The work reflects lessons from the COVID-19 pandemic, when shortages of masks, drugs, and testing supplies exposed how fragile and concentrated US medical manufacturing had become. By identifying weak points in advance, federal officials aim to shore up capacity before the next crisis rather than scramble during one. For hospitals and suppliers, the mapping could shape future procurement, stockpiling, and investment decisions tied to national preparedness.
Sources